Back to Authors

Koschel, Dirk

Mayo Clinic

Fachkrankenhaus Coswig, Coswig, Germany

Citations 2

Effects of nintedanib on progression of ILD in patients with fibrosing ILDs and a progressive phenotype: further analyses of the INBUILD trial
Koschel, Dirk, Flaherty, Kevin R. , Wells, Athol U. , Devaraj, Anand, Walsh, Simon , Moua, Teng , Goeldner, Rainer-Georg , Schlenker‐Herceg, Rozsa, Brown, Kevin K. , Cottin, Vincent , Inoue, Yoshikazu , Richeldi, Luca , Kolb, Martin R.J. , Stowasser, Susanne

Pneumologie | October 26, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0041-1723315 Get It

Effects of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) Taking Anti-Acid Therapy
Kreuter, Michael , Glazer, Craig S., Kitamura, Hitoshi, Koschel, D., Moua, Teng , Röhr, Klaus, Brown, KK, investigators, on behalf of the INBUILD trial, Koschel, Dirk, Müller, H., Stowasser, Susanne , Rohr, K.B.

TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD | May 4, 2021 | Volume: No volume available | Issue: No issue available | Pages: A1906-A1906

10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1906 Get It